DERM Journey Medical
- 3.620
- +0.030+0.84%
Journey Medical News
Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and
Journey Medical | 10-Q: Quarterly report
Earnings Call Summary | Journey Medical(DERM.US) Q1 2024 Earnings Conference
The following is a summary of the Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript:Financial Performance:Journey Medical reported Q1 revenue of $13 million, a 7% increase year-over-
Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript
Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript
Express News | Journey Medical Q1 2024 Adj EPS $(0.53) Misses $(0.23) Estimate, Sales $13.000M Miss $14.098M Estimate
Express News | Journey Medical Corp: Qtrly Shr Loss $0.53
Journey Medical 1Q Rev $13M >DERM
Journey Medical 1Q Rev $13M >DERM
Express News | Journey Medical Corporation Q1 Net Income USD -10.4 Million
Express News | Journey Medical Corporation Q1 Revenue USD 13 Million
Press Release: Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Notable Earnings After Monday's Close
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
Journey Medical Corporation ("Journey Medical" or the "Company") (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its first quarter 2024 financial results after the U.S. financial markets close on Monday, May 13, 2024. Journey Medical management will conduct a conference call and audio webcast on Monday, May 13, 2024 at 4:30 p.m. ET.
Journey Medical Corp Announces CFO Promotion and Strategic Update
Express News | Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
There's No Escaping Journey Medical Corporation's (NASDAQ:DERM) Muted Revenues Despite A 30% Share Price Rise
Those holding Journey Medical Corporation (NASDAQ:DERM) shares would be relieved that the share price has rebounded 30% in the last thirty days, but it needs to keep going to repair the recent damage
Journey Medical And 2 Other Stocks Under $4 Insiders Are Buying
The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders
VERI, CHEK and MESO Are Among Pre Market Gainers
Journey Medical(DERM.US) Director Buys US$30,400 in Common Stock
$Journey Medical(DERM.US)$ Director ROSENWALD LINDSAY A MD purchased 10,000 shares of Common Stock on Mar 25, 2024 at an average price of $3.04 for a total value of $30,400.Source: Announcement What i
Journey Medical Independent Director Acquires 45% More Stock
Potential Journey Medical Corporation (NASDAQ:DERM) shareholders may wish to note that the Independent Director, Justin Smith, recently bought US$104k worth of stock, paying US$3.47 for each share.
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersStoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's market cap stands at $498.5 million. The company's, Q4 earnings came out
Analysis
Price Target
No Data
